Literature DB >> 19652103

Poor performance of body mass index as a marker for hypercholesterolemia in children and adolescents.

Joyce M Lee1, Achamyeleh Gebremariam, Paula Card-Higginson, Jennifer L Shaw, Joseph W Thompson, Matthew M Davis.   

Abstract

OBJECTIVE: To evaluate the test performance of specific body mass index (BMI) percentile cutoffs for detecting children/adolescents with hypercholesterolemia.
DESIGN: Cross-sectional analysis.
SETTING: National Health and Nutrition Examination Survey 1999-2004. PARTICIPANTS: Population-based sample of children (aged 3-18 years) with nonfasting total cholesterol (TC) and high-density lipoprotein (HDL) cholesterol levels and adolescents (aged 12-18 years) with fasting low-density lipoprotein (LDL) cholesterol and triglyceride (TG) levels. MAIN OUTCOME MEASURES: Individuals were classified as having hypercholesterolemia if they had a TC level greater than 200 mg/dL, HDL cholesterol level less than 35 mg/dL, LDL cholesterol level greater than 130 mg/dL, or TG level greater than 150 mg/dL, and sensitivity, specificity, and likelihood ratios were calculated for specific BMI percentiles. Receiver operating characteristic curves were constructed and area under the curve (AUC) was calculated.
RESULTS: Receiver operating characteristic curves using BMI percentiles to predict abnormal levels of TC and LDL cholesterol had AUC values (0.60 for TC level and 0.63 for LDL cholesterol level) that were less than the threshold of acceptable discrimination (between 0.7-0.8). Body mass index percentiles provided better discrimination for detecting children with abnormal HDL cholesterol and TG levels, with AUC values approaching levels of acceptable discrimination (0.69 and 0.72, respectively), although there are no specific guidelines regarding management of children with these abnormalities.
CONCLUSIONS: According to the American Academy of Pediatrics guidelines, abnormal levels of LDL cholesterol are used to determine which children require nutritional and pharmacologic therapy. Because BMI percentiles did not adequately identify children and adolescents with abnormal TC and LDL cholesterol levels, the new recommendations for targeted screening of obese children and adolescents may require further consideration.

Entities:  

Mesh:

Year:  2009        PMID: 19652103     DOI: 10.1001/archpediatrics.2009.109

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  5 in total

1.  The 1p13.3 LDL (C)-associated locus shows large effect sizes in young populations.

Authors:  Joseph M Devaney; Paul D Thompson; Paul S Visich; William A Saltarelli; Paul M Gordon; E Funda Orkunoglu-Suer; Heather Gordish-Dressman; Brennan T Harmon; Margaret K Bradbury; Karuna Panchapakesan; Rahul Khianey; Monica J Hubal; Priscilla M Clarkson; Linda S Pescatello; Robert F Zoeller; Niall M Moyna; Theodore J Angelopoulos; William E Kraus; Eric P Hoffman
Journal:  Pediatr Res       Date:  2011-06       Impact factor: 3.756

2.  Evalution of Serum Lipid Profiles in Turkish Children Aged Two to Eighteen Years.

Authors:  D Toprak; A Bukulmez; N Dogan; O Oztekin; T Koken
Journal:  West Indian Med J       Date:  2014-02-24       Impact factor: 0.171

3.  Cardio-metabolic risk screening among adolescents: understanding the utility of body mass index, waist circumference and waist to height ratio.

Authors:  K W Bauer; M D Marcus; L El ghormli; C L Ogden; G D Foster
Journal:  Pediatr Obes       Date:  2014-12-17       Impact factor: 4.000

4.  The Impact of Obesity Assessed by Different Criteria on the Metabolic Parameters in Children and Adolescents in Georgia.

Authors:  Nino Tskhvedadze; Shota Janjgava; David Tananashvili; Elene Giorgadze
Journal:  Glob Pediatr Health       Date:  2022-05-12

5.  Adiposity, biological markers of disease, and insulin resistance in Mexican American adolescents, 2004-2005.

Authors:  Anne R Rentfro; Jeanette C Nino; Rosa M Pones; Wendy Innis-Whitehouse; Cristina S Barroso; Mohammed H Rahbar; Joseph B McCormick; Susan P Fisher-Hoch
Journal:  Prev Chronic Dis       Date:  2011-02-15       Impact factor: 2.830

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.